AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Ramsay Health Care (ASX:RHC) reported 7.0% rise in core earnings per share to 279.8 cents and 6.8% rise in core net profit to $579.3 million for the year ended 30 June 2018. Groupâs revenue increased 5.4% to $9.2 billion including 5.5% growth in Australia/Asia segment, 0.3% growth in France, and decline of 5.2% in United Kingdom arising from significant downturn in NHS volumes.
Groupâs earnings before interest tax, depreciation and amortization (EBITDA) rose to $1.4 billion, an increase of 6.2% on FY17. However, statutory reported net profit after tax of the company declined by 20.6% to $388.3 million, reflecting net non-core items of $191.0 million in FY18. [optin-monster-shortcode id="wxhmli4jjedneglg1trq"]
Private Hospital operator Ramsay Health Care has completed projects with gross capital investment of $171 million in fiscal 2018, which includes net increase of four beds, seven theaters and 21 consulting suites.
Fully-franked final dividend of 86.5 cents was announced during the year, taking the full year 2018 dividend to 144.0 cents which is 7.1% more than previous year dividend payment.
After taking into consideration the anticipation of higher interest and tax in FY19, the company aims of up to 2% growth in Core EPS.
As company reported downfall in net profit after tax, Ramsayâs stock slipped by 7.221% to $53.960 on 30 August 2018 (3:32 PM AEST).
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a companyâs prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkineâs team of analysts bought you handpicked report for âTop 25 Dividend Stocks For 2018.â
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
